The following is a recap of  developments that have had or will have an impact on your investment in MDEChem, Inc. 

In, April 2010 MDEChem concluded an Agreement with Proven Engineering and Technologies, LLC of Houston, Texas for various applications of MDEChem's non oil based formulations

In August 2009 MDEChem concluded a License Agreement with Best Tech Brands of Houston Texas for various applications of the License Agreement concluded with EnviroFuels, LLC in July 2009. This License with Best Tech Brands involves a monetary payment to MDEChem and a royalty arrangement. In April of 2010 Best Tech Brands and MDEChem mutually terminated this Agreement

In July 2009 MDEChem concluded a License Agreement with EnviroFuels, LLC for the use of base EnviroFuels, LLC technology in the  manufacture , marketing and distribution of propriatary non oil based formulations developed by MDEChem, Inc.   This License involves a sales based Royalty to EnviroFuels, LLC

 In May 2009 the shareholders in attendance at our Annual Shareholders meeting voted in as  Directors: Fred Fischer, Shannon Sauer and Paul Sack.

In May 2009 MDEChem concluded a product development agreement with North America Marketing of The Woodlands, Texas for various applications of our aqueous based formulation.

In April 2009, Sellion, a brand development company, with a focus on medical products that provide solutions for today’s most  common ailments submitted two MaxHeal products to CVS and Walmart. We continue to work with those vendors on these products which are a Bed Sore Relief Cream and a Gout Relief Cream.  Sellion was engaged by MDEChem on May 1, 2008 to aid MaxHeal in the marketing, logistics, product development and the sales/ distribution of our products starting with MaxHeal™ Skin Restoration Gel. 

In January 2009 Planck Consulting LLC, submitted a for MaxHeal, Inc. a  Provisional Patent #61/143,884 to protect our medical technology and is currently in the process of submitting by year end a new patent for our medical technology.  Planck also provides us with business consulting services and assists MDEChem’s business development efforts such as: licensing agreements, identifying new products, developing and documenting new "USE" patents, creating new product pamphlets, new product documentation and assists in the development of new business contacts. Planck Consulting LLCwas engaged by MDEChem via an "Agreement" signed May 1. 2008.

March 2008 in order to raise capital necessary to continue operations the company sold 10% of our Class A EnviroFuels, LLC Units in order to go forward with our market and product development programs. MDEChem currently owns 50,000 Units of EnviroFuels, LLC.

In January 2008 MDEChem obtained at no cost the trademark for "Phosfamid" from EnviroFuels, LLC and we registered it for our use in the future.

In mid 2008 a 504 offering intended to raise $1,000,000 through the sale of MaxHeal, Inc shares was finalized.  The marketing of this Offering failed and the company has since withdrawn this Offering until we can find a qualified group to handle the marketing

A License Agreement was signed on June 1, 2008 between MDEChem, Inc. and Falcion,LLC. This license granted the exclusive agricultural/horticultural application and treatment rights to Falcion, LLC. This license provides exclusive and worldwide development and marketing rights of products, applications and treatments based upon MDEChem’s patented technology.   Falcion encountered difficulties consummating consistent testing and we mutually agreed to terminated this license in June 2009.

In July 2007 the first domestically produced MaxHeal product was packaged at FNC Medical in Ventura, CA. This production consisted of 27,000 1.75 oz tubes of MaxHeal Skin Restoration Gel.

In August 2007 MDEChem/MaxHeal leased a 1600 S.F. building in Floresville, TX for office, lab work and warehousing.